337: Eli Lilly CEO on Trump, obesity drugs, and a guidance miss

We're live at the J.P Morgan Healthcare Conference in San Francisco! We bring on Eli Lilly CEO Dave Ricks for a wide-ranging conversation about his views on the incoming Trump administration, the effects of Medicare's drug price negotiation, Lilly's recent disappointing guidance, pricing of the company's obesity medication Zepbound, and more. We also discuss the latest news from the J.P. Morgan conference, including M&A deals, licensing of drugs from China, and the broader sentiment in the industry.

Episode metadata supplied by the publisher feed · Published Jan 15, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

337: Eli Lilly CEO on Trump, obesity drugs, and a guidance miss

0:00 58:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 58 minutes long.

When was this The Readout Loud episode published?

This episode was published on January 15, 2025.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!